Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?

Author:

Livingston Mark12ORCID,Hashmi Syeda F.1,Ramachandran Sudarshan34567,Laing Ian8,Heald Adrian910ORCID

Affiliation:

1. Department of Clinical Biochemistry, Black Country Pathology Services  Walsall Manor Hospital Walsall UK

2. Faculty of Science and Engineering, School of Medicine and Clinical Practice The University of Wolverhampton Wolverhampton UK

3. Department of Clinical Biochemistry University Hospitals Birmingham NHS Foundation Trust Birmingham UK

4. Department of Clinical Biochemistry University Hospitals of North Midlands Stoke‐on‐Trent UK

5. Institute of Science and Technology Keele University Keele UK

6. Faculty of Health Sciences Staffordshire University Stoke‐on‐Trent UK

7. Department of Mechanical and Aerospace Engineering Brunel University London UK

8. Department of Clinical Biochemistry Royal Preston Hospital Preston UK

9. Department of Endocrinology and Diabetes Salford Royal Hospital Salford UK

10. The School of Medicine and Manchester Academic Health Sciences Centre Manchester University Manchester UK

Abstract

AbstractObjective and DesignMacroprolactinemia may influence the interpretation of serum prolactin levels—a recognised phenomenon since 1981. The degree of macroprolactinaemia over time is less well described. We determined how macroprolactin status (based on polyethylene glycol (PEG) precipitation) varied by analysing serial measurements in hyperprolactinaemic individuals over a period of 9 years.Patients and MeasurementsResults from 1810 individuals were included. All serum total prolactin results (measured using Roche Cobas 8000 analyser) were extracted from the laboratory information system for the period 1 January 2012 to 1 April 2021, along with relevant patient demographic/test data. Samples with a macroprolactin screening test performed (on samples with prolactin > 700 miu/L) were included in the main analysis.ResultsDuring the study period, 2782 macroprolactin checks were performed (12.5% of all prolactin tests) in 1810 individuals (599 males/2183 females, median‐age: 35, interquartile range: 25–47, range: 16–93 years). Multiple macroprolactin checks were carried out on 465 patients (1437 measurements) with 94 patients (141 measurements) screening positive (<60% recovery). Only 19 patients (18 female) had at least one result above and one below the 60% screening cut‐off, with 10 of these patients having results close to the 60% cut‐off; in 9 patients, results were clearly different between repeat samples. In seven cases, the adjusted monomeric prolactin showed a potentially clinically significant difference.ConclusionsIn this study, only 19/465 patients appeared to change macroprolactin status based on a 60% PEG recovery cut‐off. The majority of these 19 patients were on antipsychotic/antidepressant medication(s) or had a prolactinoma; in only 7 did monomeric prolactin change significantly. This suggests that once macroprolactin status has been determined, clinical decision making is rarely affected by repeating it.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3